These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1486119)
1. 99mTc-sestamibi: its clinical role as a viability agent. Marzullo P; Sambuceti G J Nucl Biol Med (1991); 1992; 36(3):259-66. PubMed ID: 1486119 [TBL] [Abstract][Full Text] [Related]
2. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Udelson JE; Coleman PS; Metherall J; Pandian NG; Gomez AR; Griffith JL; Shea NL; Oates E; Konstam MA Circulation; 1994 Jun; 89(6):2552-61. PubMed ID: 8205664 [TBL] [Abstract][Full Text] [Related]
3. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium. Sciagrà R; Bisi G; Santoro GM; Rossi V; Fazzini PF Am J Card Imaging; 1995 Jul; 9(3):157-66. PubMed ID: 7549355 [TBL] [Abstract][Full Text] [Related]
4. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541 [TBL] [Abstract][Full Text] [Related]
5. [Identification of viable myocardium in ischemic heart disease with severe left ventricular contractile dysfunction: comparison of myocardial scintigraphy with 99mTc-sestamabi and with 201-thallium]. Brandao S; Cagnac R; Roncalli J; Lotterie JA; Elbaz M; Richez F; Galinier M; Carrie D; Alibelli-Chemarin MJ Arch Mal Coeur Vaiss; 2005 Jun; 98(6):620-7. PubMed ID: 16007815 [TBL] [Abstract][Full Text] [Related]
6. Rest-redistribution thallium-201 and rest technetium-99m-sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction. Marcassa C; Galli M; Cuocolo A; Scappellato F; Maurea S; Salvatore M J Nucl Med; 1997 Mar; 38(3):419-24. PubMed ID: 9074530 [TBL] [Abstract][Full Text] [Related]
7. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability? Caner B; Beller GA Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932 [TBL] [Abstract][Full Text] [Related]
8. Comparison of technetium-99m sestamibi left ventricular wall motion and perfusion studies with thallium-201 perfusion imaging: in search of the combination of variables with the highest accuracy in predicting coronary artery disease. Verzijlbergen JF; Zwinderman AH; Ascoop CA; van der Wall EE; Niemeyer MG; Pauwels EK Eur J Nucl Med; 1996 May; 23(5):550-9. PubMed ID: 8698061 [TBL] [Abstract][Full Text] [Related]
9. Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy. Cuocolo A; Maurea S; Pace L; Nicolai E; Nappi A; Imbriaco M; Trimarco B; Salvatore M Eur J Nucl Med; 1993 Dec; 20(12):1186-92. PubMed ID: 8299654 [TBL] [Abstract][Full Text] [Related]
10. Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis. Maurea S; Cuocolo A; Pace L; Nicolai E; Nappi A; Imbriaco M; Morisco C; Chiariello M; Trimarco B; Salvatore M Eur J Nucl Med; 1993 Jun; 20(6):502-10. PubMed ID: 8339733 [TBL] [Abstract][Full Text] [Related]
11. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. Marzullo P; Sambuceti G; Parodi O J Nucl Med; 1992 Nov; 33(11):1925-30. PubMed ID: 1432150 [TBL] [Abstract][Full Text] [Related]
12. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. Marzullo P; Sambuceti G; Parodi O; Gimelli A; Picano E; Giorgetti A; L'Abbate A J Nucl Cardiol; 1995; 2(4):309-16. PubMed ID: 9420805 [TBL] [Abstract][Full Text] [Related]
13. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Dakik HA; Howell JF; Lawrie GM; Espada R; Weilbaecher DG; He ZX; Mahmarian JJ; Verani MS Circulation; 1997 Nov; 96(9):2892-8. PubMed ID: 9386154 [TBL] [Abstract][Full Text] [Related]
14. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Marzullo P; Parodi O; Reisenhofer B; Sambuceti G; Picano E; Distante A; Gimelli A; L'Abbate A Am J Cardiol; 1993 Jan; 71(2):166-72. PubMed ID: 8421978 [TBL] [Abstract][Full Text] [Related]
15. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime. Berman DS; Kiat H; Maddahi J Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100 [TBL] [Abstract][Full Text] [Related]
17. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372 [TBL] [Abstract][Full Text] [Related]
18. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities. Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553 [TBL] [Abstract][Full Text] [Related]
19. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377 [TBL] [Abstract][Full Text] [Related]
20. Maldistribution of regional myocardial perfusion at rest in patients with coronary artery disease and no previous myocardial infarction, evidenced by 99mTc-Sestamibi scintigraphy. Marcassa C; Galli M; Parodi O; Marzullo P; Pirelli S; Inglese E; Giubbini R; Verna E; Santoro GM; Bisi G J Nucl Biol Med (1991); 1994 Sep; 38(3):495-501. PubMed ID: 7865546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]